9 Best Articles on Cancer
The most useful articles on cancer from around the web—beginners to advanced—curated by thought leaders and our community. We focus on timeless pieces and update the list whenever we discover new, must-read articles or videos—make sure to bookmark and revisit this page.
Top 5 Cancer Articles
At a glance: these are the articles that have been most read, shared, and saved on cancer by Refind users in 2023 so far.
- These Engineered Cells Are Super Soldiers That Hunt Down Cancers
- Bacteria can be engineered to fight cancer in mice. Human trials are coming.
- A Universal Cancer Treatment?
- Million-year-old viruses help fight cancer, say scientists
- The race to supercharge cancer-fighting T cells
Short on time? Check out these useful short articles on cancer—all under 10 minutes.
Bacteria can be engineered to fight cancer in mice. Human trials are coming.
We’re crawling with microbes, and scientists want to use them to treat disease.
These Engineered Cells Are Super Soldiers That Hunt Down Cancers
A new therapy combines two big advances, CRISPR and CAR-T, to create personalized immune cells that seek and destroy specific cancers.
Million-year-old viruses help fight cancer, say scientists
A discovery gives experts new ideas for developing vaccines to treat or even prevent cancer.
«The study, published in the journal Nature, describes how this happens naturally in the body but the researchers want to enhance that effect by developing vaccines to teach the body how to hunt for endogenous retroviruses.»
A Universal Cancer Treatment?
A medicine that disrupts the DNA replication of cancer cells may be within reach.
The race to supercharge cancer-fighting T cells
With a slew of tools to trick out immune cells, researchers are expanding the repertoire of CAR-T therapies.
These are some of the most-read long-form articles on cancer.
Phenotypic plasticity and genetic control in colorectal cancer evolution
Intratumour genetic ancestry only infrequently affects gene expression traits and subclonal evolution in colorectal cancer, with most genetic intratumour variation having no detected phenotypic…
Steadfast but nimble: CEO Christi Shaw on cancer treatment’s cutting edge
Kite’s CEO discusses the company’s CAR T-cell therapies and what it means to put patients first.
A Clever New Strategy for Treating Cancer, Thanks to Darwin
Most advanced-stage cancers mutate, resisting drugs meant to kill them. Now doctors are harnessing the principles of evolution to thwart that lethal adaptation.
Why are people still dying of cancer? — Aeon Essays
A critical mass of medical knowledge could soon end the death threat of cancer, but politics stands in the way
We monitor hundreds of publications, blogs, newsletters, and news sources in Cancer, including:
Cutting-edge science, unraveled in award-winning journalism by the very brightest living thinkers. Click the link to subscribe to the newsletter.
Chronicling technological progress in AI, robotics, health, & exponential tech. By @singularityu.
MIT Technology Review
Our in-depth reporting on innovation reveals and explains what’s really happening now to help you know what’s coming next. http://technologyreview.com/newsletters
McKinsey & Company
Since 1926, the trusted advisor to the world's leading businesses, governments, and institutions. 130+ offices in 65+ countries.
Massachusetts Institute of Technology (MIT)
The Massachusetts Institute of Technology is a world leader in research and education. Related accounts: @MITevents @MITstudents @MIT_alumni
What is Refind?
Every day Refind picks the most relevant links from around the web for you. Picking only a handful of links means focusing on what’s relevant and useful. We favor timeless pieces—links with long shelf-lives, articles that are still relevant one month, one year, or even ten years from now. These lists of the best resources on any topic are the result of years of careful curation.
How does Refind curate?
It’s a mix of human and algorithmic curation, following a number of steps:
- We monitor 10k+ sources and 1k+ thought leaders on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
- In addition, our users save links from around the web using our Save buttons and our extensions.
- Our algorithm processes 100k+ new links every day and uses external signals to find the most relevant ones, focusing on timeless pieces.
- Our community of active users gets the most relevant links every day, tailored to their interests. They provide feedback via implicit and explicit signals: open, read, listen, share, mark as read, read later, «More/less like this», etc.
- Our algorithm uses these internal signals to refine the selection.
- In addition, we have expert curators who manually curate niche topics.
The result: lists of the best and most useful articles on hundreds of topics.
How does Refind detect «timeless» pieces?
We focus on pieces with long shelf-lives—not news. We determine «timelessness» via a number of metrics, for example, the consumption pattern of links over time.
How many sources does Refind monitor?
We monitor 10k+ content sources on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
Which sources does Refind monitor on cancer?
We monitor hundreds of sources on cancer, including Nautilus Magazine, Singularity Hub, MIT Technology Review, McKinsey & Company, Massachusetts Institute of Technology (MIT), and many more.
Can I submit a link?
Indirectly, by using Refind and saving links from outside (e.g., via our extensions).
How can I report a problem?
When you’re logged-in, you can flag any link via the «More» (...) menu. You can also report problems via email to email@example.com
Who uses Refind?
200k+ smart people start their day with Refind. To learn something new. To get inspired. To move forward. Our apps have a 4.9/5 rating.
Is Refind free?
Yes, it’s free!
How can I sign up?
Head over to our homepage and sign up by email or with your Twitter or Google account.